CN109512937A - 一种降血脂的药物及其制作方法 - Google Patents
一种降血脂的药物及其制作方法 Download PDFInfo
- Publication number
- CN109512937A CN109512937A CN201710848167.7A CN201710848167A CN109512937A CN 109512937 A CN109512937 A CN 109512937A CN 201710848167 A CN201710848167 A CN 201710848167A CN 109512937 A CN109512937 A CN 109512937A
- Authority
- CN
- China
- Prior art keywords
- parts
- drug
- blood lipid
- reducing blood
- medicinal extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 229940079593 drug Drugs 0.000 title claims abstract description 28
- 239000008280 blood Substances 0.000 title claims abstract description 25
- 210000004369 blood Anatomy 0.000 title claims abstract description 25
- 150000002632 lipids Chemical class 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 13
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 13
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 13
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 13
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 13
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 13
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 13
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 13
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 13
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 13
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 13
- 239000009636 Huang Qi Substances 0.000 claims abstract description 13
- 241001646828 Platostoma chinense Species 0.000 claims abstract description 13
- 241000405414 Rehmannia Species 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims description 33
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 241001092040 Crataegus Species 0.000 claims description 12
- 241000758769 Houttuynia Species 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- 238000005469 granulation Methods 0.000 claims description 9
- 230000003179 granulation Effects 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 229920001353 Dextrin Polymers 0.000 claims description 7
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000007888 film coating Substances 0.000 claims description 2
- 238000009501 film coating Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000004064 recycling Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 238000000034 method Methods 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- -1 tabletting Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种降血脂的药物及其制备方法，所述药物主要由淫羊藿、玉竹、山楂、地黄、陈皮、鱼腥草、甘草、黄芪和仙人草制作而成。处方中各原料具有很好的协同作用，共奏具有降低血脂的作用，可用于治疗高血压；疗效显著，治疗周期短，安全无副作用。
Description
技术领域
本发明涉及一种降血脂的药物及其制作方法，属于药品技术的领域。
技术背景
现在高血压、高血脂已经是一种常见的高发疾病，随着人们生活水平的提高，人们的饮食越来越丰富，人们摄取的营养也越来越丰富，但是相对的人们的运动量越来越小，从而造成了高血压、高血脂的高发。高血脂对人体的危害非常之大，并且往往伴随有高血压，不及时治疗会引起脑卒中、冠心病、脑梗塞、肾衰竭等恶性疾病，严重影响人们的身体健康。
针对上述疾病，虽然目前用于降血脂的药物有很多，但是大多数药物只是针对药效缓慢，治疗周期长。
发明内容：
本发明的目的在于，提供一种降血脂的药物及其制作方法。所述药物具有降低血脂的作用，可用于治疗高血压；疗效显著，治疗周期短，安全无副作用。
为解决上述技术问题，本发明采用以下技术方案实现：
一种降血脂的药物，按重量份计算，主要由淫羊藿10-40份、玉竹20-40份、山楂10-30份、地黄10-30份、陈皮20-30份、鱼腥草10-30份、甘草20-40份、黄芪30-50份和仙人草20-40份制作而成。
前述的降血脂的药物，按重量份计算，主要由淫羊藿15-35份、玉竹25-35份、山楂15-25份、地黄15-25份、陈皮23-27份、鱼腥草15-25份、甘草25-35份、黄芪35-45份和仙人草25-35份制作而成。
前述的降血脂的药物，按重量份计算，主要由淫羊藿20份、玉竹30份、山楂20份、地黄20份、陈皮25份、鱼腥草20份、甘草30份、黄芪40份和仙人草30份制作而成。
一种前述的降血脂的药物的制作方法，取上述药物，可以加辅料，也可以不加辅料，制成口服制剂。
前述的降血脂的药物的制作方法，所述口服制剂为颗粒剂、胶囊剂、片剂、丸剂、散剂或霜剂。
前述的降血脂的药物的制作方法，所述颗粒剂这样制作：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得。
前述的降血脂的药物的制作方法，所述胶囊剂的制作方法为：取上述药物，用6倍量70%的乙醇回流提取2次，每次1小时，提取液过滤，滤液回收乙醇并浓缩成50-60℃时相对密度为1.20-1.25的浸膏，另取浸膏量30%的淀粉和0.7%的硬脂酸镁与浸膏混匀，用60%的乙醇制粒，干燥，粉碎，填充胶囊，即得。
前述的降血脂的药物的制作方法，所述片剂的制作方法为：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与上述混合粉及浸膏量20%的淀粉混匀，压片，包薄膜衣，即得。
与现有技术相比，本发明所述药物主要由淫羊藿、玉竹、山楂、地黄、陈皮、鱼腥草、甘草、黄芪和仙人草制作而成。处方中各原料具有很好的协同作用，共奏具有降低血脂的作用，可用于治疗高血压；疗效显著，治疗周期短，安全无副作用。
具体实施方式：
实施例1.
配方：淫羊藿20kg、玉竹30kg、山楂20kg、地黄20kg、陈皮25kg、鱼腥草20kg、甘草30kg、黄芪40kg和仙人草30kg。
工艺：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得颗粒剂。
规格：5g/袋。
用法用量：每次5-10g，每日2-3次。
实施例2.
配方：淫羊藿35kg、玉竹35kg、山楂25kg、地黄25kg、陈皮27kg、鱼腥草25kg、甘草35kg、黄芪45kg和仙人草35kg。
工艺：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得颗粒剂。
规格：5g/袋。
用法用量：每次5-10g，每日2-3次。
实施例3.
配方：淫羊藿15kg、玉竹25kg、山楂15kg、地黄15kg、陈皮23kg、鱼腥草15kg、甘草25kg、黄芪35kg和仙人草25kg。
工艺：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得颗粒剂。
规格：5g/袋。
用法用量：每次5-10g，每日2-3次。
实施例4.
配方：淫羊藿40kg、玉竹40kg、山楂30kg、地黄30kg、陈皮30kg、鱼腥草30kg、甘草40kg、黄芪50kg和仙人草40kg。
工艺：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得颗粒剂。
规格：5g/袋。
用法用量：每次5-10g，每日2-3次。
实施例5.
配方：淫羊藿10kg、玉竹20kg、山楂10kg、地黄10kg、陈皮20kg、鱼腥草10kg、甘草20kg、黄芪30kg和仙人草20kg。
工艺：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得颗粒剂。
规格：5g/袋。
用法用量：每次5-10g，每日2-3次。
Claims (8)
1.一种降血脂的药物，其特征在于：按重量份计算，主要由淫羊藿10-40份、玉竹20-40份、山楂10-30份、地黄10-30份、陈皮20-30份、鱼腥草10-30份、甘草20-40份、黄芪30-50份和仙人草20-40份制作而成。
2.如权利要求1所述的降血脂的药物，其特征在于：按重量份计算，主要由淫羊藿15-35份、玉竹25-35份、山楂15-25份、地黄15-25份、陈皮23-27份、鱼腥草15-25份、甘草25-35份、黄芪35-45份和仙人草25-35份制作而成。
3.如权利要求2所述的降血脂的药物，其特征在于：按重量份计算，主要由淫羊藿20份、玉竹30份、山楂20份、地黄20份、陈皮25份、鱼腥草20份、甘草30份、黄芪40份和仙人草30份制作而成。
4.一种如权利要求1-3中任一项所述的降血脂的药物的制作方法，其特征在于：取上述药物，可以加辅料，也可以不加辅料，制成口服制剂。
5.如权利要求4所述的降血脂的药物的制作方法，其特征在于：所述口服制剂为颗粒剂、胶囊剂、片剂、丸剂、散剂或霜剂。
6.如权利要求5所述的降血脂的药物的制作方法，其特征在于：所述颗粒剂这样制作：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与浸膏量20%的淀粉和20%的糊精粉混合制粒，干燥，即得。
7.如权利要求5所述的降血脂的药物的制作方法，其特征在于：所述胶囊剂的制作方法为：取上述药物，用6倍量70%的乙醇回流提取2次，每次1小时，提取液过滤，滤液回收乙醇并浓缩成50-60℃时相对密度为1.20-1.25的浸膏，另取浸膏量30%的淀粉和0.7%的硬脂酸镁与浸膏混匀，用60%的乙醇制粒，干燥，粉碎，填充胶囊，即得。
8.如权利要求5所述的降血脂的药物的制作方法，其特征在于：所述片剂的制作方法为：取上述药物，加10倍量水煎煮3次，每次1.5h，过滤，合并煎煮液，浓缩成50-60℃时相对密度为1.15-1.20的浸膏，浸膏与上述混合粉及浸膏量20%的淀粉混匀，压片，包薄膜衣，即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710848167.7A CN109512937A (zh) | 2017-09-19 | 2017-09-19 | 一种降血脂的药物及其制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710848167.7A CN109512937A (zh) | 2017-09-19 | 2017-09-19 | 一种降血脂的药物及其制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109512937A true CN109512937A (zh) | 2019-03-26 |
Family
ID=65768408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710848167.7A Pending CN109512937A (zh) | 2017-09-19 | 2017-09-19 | 一种降血脂的药物及其制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109512937A (zh) |
-
2017
- 2017-09-19 CN CN201710848167.7A patent/CN109512937A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1994451B (zh) | 治疗抑郁症的中药组合物及其制备方法和其应用 | |
| CN101530562A (zh) | 一种治疗女性肾阴虚的药物组合 | |
| CN116370556B (zh) | 一种活血祛瘀、益气安神的中药组合物及其制备方法 | |
| CN109512937A (zh) | 一种降血脂的药物及其制作方法 | |
| CN104435567A (zh) | 一种含绞股蓝的治疗痛风的中药组合物 | |
| CN104337909B (zh) | 一种含九香虫的治疗痛风的中药组合物 | |
| CN101480472B (zh) | 调血脂的药物及生产方法 | |
| CN107961317A (zh) | 一种降血脂的药物及其制作方法 | |
| CN106581299B (zh) | 一种改善中老年肾气虚证的中药组合物及其应用 | |
| CN102068674A (zh) | 一种治疗慢性泄泻的中药组合物及其制备方法 | |
| CN1242800C (zh) | 治疗脾胃阴虚型萎缩性胃炎的中药制剂 | |
| CN105147994A (zh) | 一种治疗糖尿病的中药制剂及其制备方法 | |
| CN107970313A (zh) | 一种治疗肝癌的药物及其制作方法 | |
| CN109512899A (zh) | 一种治疗胃病的药物及其制作方法 | |
| CN1985986A (zh) | 一种用于泄泻日久、胃腕疼痛等疾病的中药组合物 | |
| CN107970401A (zh) | 一种治疗便秘的药物及其制作方法 | |
| CN107982373A (zh) | 一种治疗胃病的药物及其制作方法 | |
| CN109512933A (zh) | 一种治疗腹泻的药物及其制作方法 | |
| CN109512985A (zh) | 一种治疗脓疱疮的药物及其制作方法 | |
| CN107348508B (zh) | 一种中药保健品及其制备方法和用途 | |
| CN107970283A (zh) | 一种治疗荨麻疹的药物及其制作方法 | |
| CN109512882A (zh) | 一种治疗便秘的药物及其制作方法 | |
| CN105148112A (zh) | 用于美白祛斑的中药组合物 | |
| CN107998342A (zh) | 一种治疗胃病的药物及其制作方法 | |
| CN106581165A (zh) | 一种治疗高血压的药物及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190326 |